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The circadian timing system is critically involved in the maintenance of fluid and electrolyte 
balance, and in blood pressure control. However, the role of peripheral circadian clocks in 
these homeostatic mechanisms remains unknown. We addressed this question in a mouse 
model carrying a conditional allele of the circadian clock gene Bmal1 and expressing the Cre 
recombinase under the endogenous promoter of the Renin gene (Bmal1lox/lox/Ren1dCre mice). 
Analysis of Bmal1lox/lox/Ren1dCre mice showed that the floxed Bmal1 allele was excised in 
the kidney. In the kidney, the BMAL1 protein expression was absent in the renin-secreting 
granular cells of the juxtaglomerular apparatus and in the collecting duct. A partial reduction 
of BMAL1 expression was observed in the medullary thick ascending limb. Functional 
analyses demonstrated that Bmal1lox/lox/Ren1dCre mice exhibit multiple abnormalities 
including an increased urine volume, changes in the circadian rhythm of urinary sodium 
excretion, an increased glomerular filtration rate (GFR) and a significant reduction in plasma 
aldosterone levels. These changes were accompanied by a reduction in blood pressure. These 
results show for the first time that local renal circadian clocks control body fluid and blood 
pressure homeostasis.   
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Circadian rhythmicity is a feature of a wide variety of physiological functions. Many of the 
functional rhythms are driven by the circadian timing system, a complex mechanism which 
coordinates all major cellular processes with geophysical time. It is thought that this 
coordination allows for the anticipatory adaptation of cells and tissues to the circadian 
changes in functional requirements. The circadian timing system is organized in a hierarchical 
manner. The masterclock of the system is located in the suprachiasmatic nucleus (SCN) of the 
hypothalamus and is synchronized to the daily light/dark cycle through the retino-
hypothalamic tract. The peripheral circadian clocks, which are present in virtually all 
peripheral tissues, are synchronized to geophysical time through a wide range of masterclock-
dependent stimuli, many of which remain unknown (reviewed in 1). It is important to note, 
however, that despite the hierarchical structure of the circadian timing system and its 
continuous resetting by environmental time-cues, the intrinsic activity of both central and 
peripheral circadian clocks is largely self-sustained. On the molecular level, the masterclock 
and peripheral clocks share similar machinery based on transcriptional/translational feedback 
loops involving transcriptional activators BMAL1, CLOCK and NPAS2 and their own 
repressors PER1, PER2 and CRY1, CRY2 (reviewed in 2).  
 The circadian timing system is critically involved in the maintenance of fluid and 
electrolyte balance, and in blood pressure (BP) control. In mice, whole-body genetic 
inactivation of any of the circadian clock transcriptional activators or repressors leads to 
either increased or decreased BP 3-6 (reviewed in 7). In clock-/- mice, the decrease in BP is 
accompanied by deep changes in circadian rhythms of urinary sodium and potassium 
excretion, loss of the circadian rhythmicity of plasma aldosterone levels and significant 
modifications in expression patterns of a great number of renal transcripts involved in 
different homeostatic functions 8. Doi et al. have shown that Cry1/Cry2 double knockout mice 
exhibit significantly increased plasma aldosterone levels resulting in salt-sensitive 
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hypertension 9. In humans, long-term misalignment of intrinsic circadian rhythms with 
geophysical time (e.g. shift-work) is increasingly recognized as a risk factor for the 
development of hypertension and progression of chronic kidney disease 10, 11. In genetic 
studies, Woon et al. have identified several polymorphisms in the promoter region of the 
human Bmal1 gene that are associated with hypertension 12. However, to what extent the 
pathogenesis of these disorders is caused by the defect in the masterclock and/or in the local 
circadian clocks in different peripheral tissues remains unknown. 
Here, we studied the role of peripheral circadian clocks in the maintenance of 
homeostasis of extracellular fluids and in BP regulation in a mouse model carrying a 
conditional allele of the circadian clock gene Bmal1 and expressing Cre recombinase under 
the endogenous promoter of the Renin gene (Bmal1lox/lox/Ren1dCre mice) 13, 14. This mouse 
model was chosen because (i) the Renin-Angiotensin-Aldosterone System (RAAS) plays the 
central role in the regulation of BP, (ii) the activity of the RAAS exhibits significant circadian 
oscillations, and (iii) the inactivation of Bmal1 results in the complete disruption of the 
molecular clock. Functional analysis revealed that Bmal1lox/lox/Ren1dCre mice exhibit multiple 
abnormalities, including defects in renal handling of sodium, water, calcium, magnesium and 
pH, significant changes in the circadian pattern of plasma aldosterone levels, an increase in 
the glomerular filtration rate (GFR) and a decrease in BP. These functional changes were 
accompanied by significant modifications in circadian patterns of mRNA expression of a 
number of renal transcripts involved in sodium, potassium and water balance. This study 
shows for the first time that local renal circadian clocks are indispensable for the maintenance 
of body fluid homeostasis and for BP control.  
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RESULTS 
Inactivation pattern of Bmal1 in Bmal1lox/lox/Ren1dCre mice.    The Bmal1lox/lox/Ren1dCre 
mice were generated by crossing mice bearing loxP sites flanking the exon 8 of the Bmal1 
gene with mice expressing Cre recombinase under the endogenous promoter of the Renin-1d 
(Ren1d) gene. The Bmal1lox/lox/Ren1dCre mice were viable and did not show any obvious 
abnormalities when compared to Ren1dCre mice used as controls (hereafter referred to as 
Control mice). As shown in Supplementary Figures 1A and 1B, they displayed a normal 
general motion activity and water-drinking behaviour, respectively. Gene expression analyses 
were performed at ZT0, the time of maximal expression of Bmal1 mRNA 15, 16; the protein 
expression was quantified at ZT4 and/or ZT16, the time of expected maximal and minimal 
expression of BMAL1 protein, respectively (ZT- circadian or Zeitgeber time, where ZT0 is 
the time of light on and ZT12 is time of light off) 17. The qPCR-based analysis of Cre mRNA 
levels in different tissues revealed highest expression in the kidney (Figure 1A). This 
correlated with the observation that the Cre-mediated excision of the floxed Bmal1 allele was 
detectable only in the kidney, as demonstrated by RT-PCR analysis of total tissue RNA using 
primers flanking the floxed region (Figure 1B). Interestingly, the Bmal1 mRNA levels were 
reduced not only in the kidney but also in the liver, thus suggesting that the circadian clock 
system in the liver is affected by the disruption of circadian clocks in renal cells (Figure 1C). 
However, immunohistochemistry showed that the vast majority of liver cells remained 
positive for Bmal1 and, Western blotting did not reveal significant difference in BMAL1 
protein expression between Control and Bmal1lox/lox/Ren1dCre mice (Supplementary Figures 
2A and 2B, respectively (ZT4)).  
Immunohistochemical analysis of Cre expression in the kidney (ZT4) showed that 
CRE protein is strongly expressed in the arterioles of juxtaglomerular apparatus but is also 
present in the cortical and medullary collecting duct (CCD and OMCD, respectively) and, at a 
 6 
weaker level, in the medullary thick ascending limb (MTAL) (Figure 2 and Supplementary 
Figure 3; the Aquaporin-2 water channel was used as a marker of the principal cell of the 
CCD and OMCD, and Uromodulin was used as a marker of the thick ascending limb). The 
distribution of Bmal1 mRNA and protein in kidneys of Control and Bmal1lox/lox/Ren1dCre 
mice was examined by qPCR performed on RNAs extracted from microdissected glomeruli or 
microdissected nephron segments, by Western probing of whole-cell lysates prepared from 
microdissected nephron segments (ZT4) and by immunohistochemistry (ZT4 and ZT16). As 
shown in Figure 3A, the Bmal1 mRNA expression was markedly reduced in the CCD and 
OMCD. A partial reduction (~60%) in Bmal1 mRNA expression was also observed in the 
MTAL. Importantly, the decrease in Bmal1 mRNA expression correlated with the deletion of 
exon 8 of the Bmal1 gene in the same nephron segments (Supplementary Figure 4). Western 
blot analysis revealed a parallel reduction of BMAL1 protein expression in the CCD, OMCD 
and MTAL (Figure 3B). Immunohistochemistry showed that BMAL1 protein is ubiquitously 
expressed in the kidney of Control mice but is absent in the juxtaglomerular cells 
(Supplementary Figures 5A (ZT4) and 5E, (ZT16)) and, in the CCD (Supplementary Figures 
5B (ZT4) and 5F (ZT16)) and OMCD (Supplementary Figures 5C (ZT4) and 5G (ZT16)) of 
Bmal1lox/lox/Ren1dCre mice. The BMAL1 protein expression in the MTAL was significantly 
reduced, however a small population of MTAL cells exhibited positive staining for BMAL1 
(Supplementary Figures 5D (ZT4) and 5H (ZT16)).  
Function of the RAAS in Bmal1lox/lox/Ren1dCre mice. To assess the circadian pattern of 
the RAAS, mice were adapted to a 12-hour light/12-hour dark cycle (LD) for 2 weeks. Tissue 
and blood samples were collected from mice sacrificed every 4 hours over the course of 
circadian cycle. As shown in Figure 4A, kidneys from Bmal1lox/lox/Ren1dCre mice exhibited a 
moderate but significant reduction in Ren1 mRNA expression (p=0.003, ANOVA, 
Supplementary Table 1). Western blot analysis revealed that renin protein levels follow a 
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circadian-like pattern in kidneys of Control mice with peak levels during the dark (activity) 
phase (Figures 4B and 4D). This pattern was disrupted in kidneys of Bmal1lox/lox/Ren1dCre 
mice (Figures 4C and 4D, p=0.039, ANOVA, Supplementary Table 1). We also performed 
qPCR analysis of Cyclooxygenase-2 (Cox-2) and Peroxisome Proliferator-Activated Receptor 
Gamma (Pparγ), two genes that have been shown to be involved in the regulation of Renin 
synthesis and/or secretion. As shown in Supplementary Figures 6A and 6B, the expression 
patterns of both, Cox-2 and Pparγ, were significantly changed in kidneys of 
Bmal1lox/lox/Ren1dCre mice. 
 To assess the function of the RAAS, we examined circadian patterns of plasma Renin 
concentration (PRC) and plasma aldosterone concentrations in Control and 
Bmal1lox/lox/Ren1dCre mice (Figure 5). As shown in Figures 5A and 5B, both the PRC and 
plasma aldosterone concentrations exhibited robust circadian rhythms (p<0.001, 
Supplementary Table 2; peak-to-trough amplitude in the circadian rhythm of PRC: 142.0% in 
Control mice, 70.4% in Bmal1lox/lox/Ren1dCre mice; peak-to-trough amplitude in the circadian 
rhythm of plasma aldosterone concentration: 216.9% in Control mice, 117.8% in 
Bmal1lox/lox/Ren1dCre mice). Interestingly, the plasma aldosterone concentration in Control 
(Ren1dCre) mice follows a biphasic pattern, whereas previous studies in mice8, rats18 or 
humans19 have shown that plasma aldosterone concentration follows a bell-shaped circadian 
curve with a single peak at the time of transition between the inactive and active periods of 
the day. A possible explanation for this phenomenon is that the Ren1dCre mice have a specific 
genetic background with only one copy of Ren1d gene and one copy of Ren2 gene. 
Importantly, the circadian phases of PRC and plasma aldosterone concentrations were 
significantly different in both Bmal1lox/lox/Ren1dCre and Control mice (PRC acrophases: ZT1 
in Control mice and ZT22 in Bmal1lox/lox/Ren1dCre mice; plasma aldosterone concentration 
acrophases: ZT9 in Control mice and ZT10 in Bmal1lox/lox/Ren1dCre mice). ANOVA revealed 
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that the plasma aldosterone concentration was significantly reduced in Bmal1lox/lox/Ren1dCre 
mice (Figure 5B, p<0.001; Supplementary Table 1), whereas the PRC was not different from 
Control mice (p=0.79, Supplementary Table 1, Figure 5A). To address the difference in 
circadian phases between the PRC and plasma aldosterone concentration we examined the 
circadian pattern of plasma angiotensinogen levels. As shown in Figure 5C and 
Supplementary Table 2, the plasma angiotensin levels exhibited circadian pattern similar to 
that of plasma aldosterone levels with the maximal values in the second half of the light 
(inactivity) phase (plasma angiotensinogen levels acrophases: ZT8 in Control mice and ZT7 
in Bmal1lox/lox/Ren1dCre mice; peak-to-trough amplitude in the circadian rhythm of plasma 
angiotensinogen levels: 44.7% in Control mice, 39.6% in Bmal1lox/lox/Ren1dCre mice). 
ANOVA revealed significant difference in plasma angiotensinogen levels between Control 
and Bmal1lox/lox/Ren1dCre mice (p=0.010, Supplementary Table 1). This difference, while 
statistically significant, was slight in absolute terms. Statistical analysis with Student’s t-test 
showed moderate difference in plasma aldosterone concentration, PRC and plasma 
angiotensinogen levels between Control and Bmal1lox/lox/Ren1dCre mice at several time-points 
of the circadian cycle. 
 
Urine and blood chemistry, renal function and blood pressure in Bmal1lox/lox/Ren1dCre mice.
 Analysis of 24-hour urine samples demonstrated that Bmal1lox/lox/Ren1dCre mice 
exhibit a mild increase in urinary volume, a decrease in urine osmolality and a tendency to 
hypercalciuria, hypermagnesuria and decreased urinary pH (Table 1). In plasma samples, a 
significant decrease in plasma osmolality and a tendency to hypochloremia were observed 
(Table 1). The glomerular filtration rate (GFR) measured at two circadian time-points (ZT6 
and ZT18) was significantly increased in Bmal1lox/lox/Ren1dCre mice (Table 1). Of note, in 
both Control and Bmal1lox/lox/Ren1dCre mice, the GFR was significantly higher at ZT18 than 
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at ZT6 (Control mice: p=0.002; Bmal1lox/lox/Ren1dCre mice: p<0.001; unpaired Student’s t-
test). 
 To assess the circadian rhythms of urinary water, sodium and potassium excretion, 
urine was collected hourly from freely moving mice housed individually in metabolic cages. 
As shown in Figure 6A, there was no apparent difference in the circadian rhythms of urinary 
water excretion. The profiles of urinary sodium and potassium excretion were compared in 
the dark (activity) phase, where the accuracy of measurement is significantly higher due to 
higher volumes of collected urines. As shown in Figures 6B and 6C, the profile of urinary 
sodium but not potassium excretion was significantly different between Control and 
Bmal1lox/lox/Ren1dCre mice (p<0.001, interaction, Supplementary Table 1). This difference 
was also present, when the profiles of urinary sodium to potassium ratio were compared 
(Figure 6D and Supplementary Table 1). Circadian expression analysis of several genes 
involved in renal sodium, potassium and water handling (αENaC, NCC, Sgk1, ROMK, Aqp2, 
Aqp3, Aqp4 and Avpr2) revealed that all the selected genes, with the exception of Avpr2, 
exhibited a moderate but significant reduction in their mRNA expression levels at different 
time points of the circadian cycle (Supplementary Figure 7). The circadian analysis of plasma 
samples showed that both sodium and potassium levels exhibit circadian rhythms 
(Supplementary Table 2), however, there was no difference between Control and 
Bmal1lox/lox/Ren1dCre mice (Supplementary Figures 8A and 8B, respectively). 
 The BP was measured in conscious unrestrained mice using telemetry. As shown in 
Figure 7, both the systolic and diastolic BP were significantly decreased in 
Bmal1lox/lox/Ren1dCre mice (blood pressure recordings over 6 days are shown in the 
Supplementary Figure 9).  
 
DISCUSSION 
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Accumulating evidence suggests that most, if not all, physiological functions are controlled 
by the circadian timing system. Although it is generally presumed that peripheral circadian 
clocks are involved in these regulatory mechanisms, there are only a limited number of 
studies that have addressed this question experimentally. For instance, Storch et al. have 
shown that the retinal intrinsic circadian clocks have a significant role in visual function 14. 
Marcheva et al. have demonstrated that the inactivation of the circadian clock in pancreatic 
islets causes diabetes mellitus due to dysfunction of β-cells 20. In the kidney, the presence of 
the high amplitude circadian rhythms in the expression of the circadian clock genes has been 
evidenced in several studies 8, 15, 16. However, the functional role of the local renal circadian 
clocks has not been studied. To address this question, we crossed mice with floxed Bmal1 
gene with mice expressing the Cre recombinase under the endogenous promoter of the renin 
gene. The latter model has been widely used for the conditional inactivation of different genes 
expressed in the renin-secreting granular cells of the juxtaglomerular apparatus in the kidney 
21-29. These studies showed that at the whole organ level the Ren1dCre is strongly expressed in 
the kidney, whereas in other tested tissues the Cre expression was at or near background 
levels 24; nota bene: clearly, however, these results did not exclude that there might be minor 
populations of Cre-expressing cells in other tissues as well. These studies also demonstrated 
that within the kidney the Cre expression is not limited to the granular cells but is also present 
in the rest of the afferent arterioles, in the interlobular renal arteries and in the tubular 
segments 13. For instance, Kurt et al. have demonstrated the presence of the CRE protein in 
the collecting duct 29. Here, we confirmed the tissue expression pattern of Ren1d Cre and 
demonstrated that in the kidney of Bmal1lox/lox/Ren1dCre mice the BMAL1 protein is absent in 
renin-secreting granular cells and in the CCD and OMCD.  Surprisingly, we also found a 
significant reduction of BMAL1 protein levels in the MTAL. Since, to our knowledge, the 
expression of the renin gene in the thick ascending limb cells has not been reported, further 
 11 
studies are needed to explain this finding. Collectively, these results suggest that (i) the Bmal1 
inactivation in Bmal1lox/lox/Ren1dCre mice is largely kidney-specific and, (ii) within the 
kidney, the inactivation of the circadian clock mechanism occurs in subpopulations of both 
vascular and tubular epithelial cells.    
Functional analysis of Bmal1lox/lox/Ren1dCre mice has shown that the local renal 
circadian clocks are involved in a wide variety of specific homeostatic functions, including 
the maintenance of sodium, water, calcium, magnesium, chloride and pH balance. 
Interestingly, the phenotype of Bmal1lox/lox/Ren1dCre mice is quite similar to that observed in 
the total (whole-body) knockout of Clock (clock-/- mice) 8, 15. The common features include 
mild polyuria, changes in the circadian pattern of urinary sodium excretion, a significant 
decrease in plasma aldosterone levels and low BP. Both models also display a circadian time 
point-dependent reduction in expression levels of several transcripts involved in water and 
sodium balance (Aqp2, Aqp4, αENaC and Sgk1). These similarities suggest that, at least in 
part, the phenotype of clock-/- mice has a renal origin.  
 Analysis of the renin-angiotensin-aldosterone axis revealed that Bmal1lox/lox/Ren1dCre 
mice exhibit significant changes in circadian patterns of renin protein and mRNA expression 
levels in the kidney. However, these changes did not result in the alteration of the PRC. 
Hence, these results indicate that factors other than renin are responsible for the decreased 
plasma aldosterone levels and low BP in Bmal1lox/lox/Ren1dCre mice. A surprising finding of 
our study is that the circadian rhythms of the PRC and plasma aldosterone concentration 
display nearly opposite circadian phases in both Control and Bmal1lox/lox/Ren1dCre mice. The 
circadian pattern of plasma aldosterone concentration in mice has been examined in several 
studies and all of them demonstrated the existence of a robust circadian rhythm that reaches 
its maximum at the time of transition between the light and dark phases 8, 9. The circadian 
variability in PRA and/or PRC has been shown in rats30, humans31 and dogs32.  To our 
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knowledge our study is the first to report the circadian pattern of the PRC in mice which 
exhibits its maximum at the time of transition between the dark and light phases. These results 
suggest a provocative hypothesis that circadian rhythmicity in plasma aldosterone 
concentrations and, potentially, in BP in mice is determined by the circadian rhythms in 
plasma angiotensinogen levels and not by the rhythmicity in available renin. To some extent 
this hypothesis is supported by the study of Kim et al, who demonstrated by using 
angiotensinogen gene titration in mice that differences in hepatic angiotensinogen mRNA 
expression were positively correlated with the expression of aldosterone synthase in adrenal 
glands and negatively correlated with renin expression in the kidney 33. Alternatively, these 
findings may suggest that circadian rhythmicity in plasma aldosterone concentrations in mice 
is mostly determined by the circadian clock-driven mechanisms in adrenal glands 9. 
 An intriguing phenotype of Bmal1lox/lox/Ren1dCre mice is glomerular hyperfiltration 
which is not associated with proteinuria or glucosuria. Since the major mechanism of 
hyperfiltration is the reduction in the vascular resistance of the afferent arteriole, it is tempting 
to speculate that the circadian clock in the afferent arteriole has a direct effect on the afferent 
arteriole contractility. An increase in nitric oxide production in tubular cells is an alternative 
mechanism that could explain this phenomenon 34, 35.  
 Collectively, functional analysis of Bmal1lox/lox/Ren1dCre mice has shown that the 
local renal circadian clocks are involved in a variety of specific renal functions and in BP 
control. The specificity in establishing genotype-phenotype correlations in circadian clock-
deficient models consists in the highly pleiotropic role of circadian clocks both on 
transcriptional/translational and functional levels. Indeed, recent estimates suggest that the 
circadian clock system controls thousands of genes in a cell-type dependent manner 36. 
Accordingly, it is not surprising that disruption of circadian clocks in renal cells results in a 
multitude of functional disturbances. In this study the circadian clock system was disrupted 
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only in a fraction of renal cell types, whereas the adult kidney is composed of more than 25 
terminally differentiated cell types, each of which possesses its own circadian clock. Future 
studies are needed to fully explore the role of each of these clock systems in renal function.  
 
 
CONCISE METHODS 
Animals The procedures used to generate, and the characterization of Bmal1lox/lox and 
Ren1dCre mice described previously 14, 17, 29, 37. The Bmal1lox/lox and Ren1dCre mice were 
crossed in order to obtain Bmal1lox/+/Ren1dCre mice. The Bmal1lox/+/Ren1dCre mice were 
crossed with either Bmal1lox/lox or Bmal1+/+ mice separately in order to obtain the 
Bmal1lox/lox/Ren1dCre and Bmal1+/+/Ren1dCre mice. 3-5 month old Bmal1lox/lox/Ren1dCre  or 
Ren1dCre (Control) male mice were used in all experiments. The animals were maintained ad 
libitum on the standard laboratory chow diet (KLIBA NAFAG diet 3800). Before all 
experiments, mice were adapted to a 12 hours light/ 12 hours dark (LD) cycle. All 
experiments with animals were performed in accordance with the Swiss guidelines for animal 
care, which conform to the National Institutes of Health animal care guidelines. 
Antibodies Anti-Cre-recombinase antibody was from Novagen. Anti-BMAL1 antibody 
has been described elsewhere 17. Anti-AQP2 and anti-GAPDH antibodies were from Santa 
Cruz, Anti-uromodulin antibody was from LS-Bio. Anti-actin antibody was from Sigma. 
Anti-Renin antibody was from Fitzgerald. Immunohistochemistry and Western blotting 
protocols are available in the Supplementary Methods. 
Metabolic cages Mice were housed in individual metabolic cages (Tecniplast, Italy). 
Urine collection was performed after a 3-day adaptation period. Urine and blood chemistry 
was analyzed as previously described 8. Hourly urine collection was performed as previously 
described 8. 
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Blood levels of RAAS components Plasma renin concentration (PRC) was determined by 
radioimmunoassay (DPC) according to a previously published protocol 38. Angiotensinogen 
concentration was determined with mouse total angiotensinogen assay kit from IBL. Plasma 
aldosterone level was measured by radioimmunoassay (DPC).  
Glomerular Filtration Rate (GFR) The GFR was determined according to the method 
described by Qi et al. 39. 
Statistics Data are presented as mean ± SEM or, as mean ± SD, as indicated in the 
corresponding figure legends. The tests used include the 2-tailed, unpaired t-test and 
ANOVA. ANOVA were performed with genotype (Control, Bmal1lox/lox/Ren1dCre), time 
(ZT0, ZT4, ZT8, ZT12, ZT16 and ZT20) and interaction between time and genotype as 
factors. When possible, the mouse-to-mouse variability was taken into account by adding a 
factor for individual mice in the ANOVA model. P values are indicated in figure legends. A P 
value less than 0.05 was considered significant. Statistical analysis of circadian oscillations 
was performed as previously described 15.  
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FIGURE LEGENDS 
 
Figure 1.   A. qPCR analysis of Cre mRNA expression (ZT0) in various tissues of Control 
(white bars) and Bmal1lox/lox/Ren1dCre (black bars) mice (see primer references in 
Supplementary Methods); data are means ± SEM, n=5.   B. RT-PCR analysis of Bmal1 
mRNA expression (ZT0) in different tissues of Bmal1lox/lox/Ren1dCre mice performed with 
primers flanking the floxed region. mRNA extracted from kidneys of whole-body (total) 
knockout of Bmal1 was used as a control (see primer sequences in Supplementary Methods).   
C. qPCR analysis of Bmal1 mRNA expression (ZT0)  in various tissues of Control (white 
bars) and Bmal1lox/lox/Ren1dCre (black bars) mice (see primer references in Supplementary 
Methods); (n=5, data are means ± SEM, n=5, * - p < 0.05, Student’s t-test). Tissues were 
collected from mice sacrificed at ZT0 (A, B and C). 
 
Figure 2.  Immunohistochemical localization of Cre recombinase in the renal cortex (ZT4). 
Strong nuclear Cre staining (black) is present in the arterioles of juxtaglomerular apparatus 
(indicated with red arrows) and in the collecting duct (indicated with blue arrows), as 
evidenced by co-staining with aquaporin-2 water channel (red). 
 
Figure 3.  mRNA (A) and protein (B) expression of Bmal1 in microdissected glomeruli 
(glom), proximal convoluted tubule (PCT), proximal straight tubule (PST), medullary thick 
ascending limb (MTAL), cortical thick ascending limb (CTAL), distal convoluted tubule 
(DCT), connecting tubule (CNT), cortical and outer medullary collecting duct (CCD and 
OMCD, respectively). Microdissection was performed at ZT4. Whole cell lysates of 20 mm 
microdissected nephron segments were used for Western blotting (B, n=3).  A: data are means 
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± SEM, n=3, * - p<0.05, ** - p<0.01, *** - p<0.005; Student’s t-test. Tissues were collected 
from mice sacrificed at ZT4. 
 
Figure 4.   Circadian patterns of renin mRNA and protein expression in Control and 
Bmal1lox/lox/Ren1dCre mice.   A. Circadian pattern of renin mRNA expression in kidneys of 
Control (black line) and Bmal1lox/lox/Ren1dCre (red line) mice (n=6/time-point). Kidneys were 
extracted from mice sacrificed at indicated circadian time-points. Data are means ± SEM, 
n=6. Significant ANOVA factors: Pgenotype=0.003, Ptime=0.013.   B. Circadian pattern of renin 
protein expression in kidneys of Control mice. This representative Western blot was 
performed on samples prepared by combining equivalent amounts of protein extracted from 
kidneys of six independent mice, in each time-point.  C. Circadian pattern of renin protein 
expression in kidneys of Bmal1lox/lox/Ren1dCre mice. This representative Western blot was 
performed on samples prepared by combining equivalent amounts of protein extracted from 
kidneys of six independent mice in each time-point.   D. Densitometry analysis of Western 
blots performed on individual samples of kidney protein extracts used in B (Control mice, 
black line) and C (Bmal1lox/lox/Ren1dCre mice, red line) (n=6/time-point). Data are means ± 
SEM, n=6, Significant ANOVA factors: Pgenotype=0.039. 
 
Figure 5.   Circadian patterns of plasma renin concentration (PRC) (A), plasma aldosterone 
levels (B) and plasma angiotensinogen concentration (C) in Control (white bars) and 
Bmal1lox/lox/Ren1dCre (black bars) mice (n=10-12/time point). Data are means ± SEM (n=10-
12, depending on time-point). Student’s t-test significance: * - p<0.05, ** - p<0.01, *** - 
p<0.005. Significant ANOVA factors: Ptime<0.001 (A); Pgenotype<0.001, Ptime<0.001, 
Pinteraction<0.001 (B); Pgenotype=0.010, Ptime<0.001 (C). 
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Figure 6.    Circadian patterns of urinary water (A), sodium (B) and potassium (C) excretion 
and urinary sodium to potassium ratios in Control (black line) and Bmal1lox/lox/Ren1dCre (red 
line) mice. Circadian pattern of urinary water excretion (A) was determined on the urine 
collected hourly over the 24-hour circadian cycle. The dynamics of urinary sodium and 
potassium excretion and of the sodium to potassium ratio (B, C and D, respectively) were 
determined on the urine collected hourly over the 12 hours of the activity phase of the 
circadian cycle (ZT12-ZT24). Data are means ± SEM, n=21. Significant ANOVA factors: 
Ptime<0.001, Pinteraction<0.001 (B); Ptime=0.010 (C); Ptime<0.001, Pinteraction<0.001 (D). 
  
Figure 7.   Systolic (A) and diastolic (B) BP in Control (black line) and Bmal1lox/lox/Ren1dCre 
(red line) mice. For each mouse a mean of 6-day recording was calculated (the 6-day 
recordings are shown in Supplementary Figure 9); then, the mean of these values was 
determined for each genotype. Data are means ± SEM, n=7 for both genotypes. Significant 
ANOVA factors: Ptime<0.001, Pgenotype<0.001 (B). 
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Table	  1.	  	  	  	  	  24h	  urine	  and	  plasma	  chemistry	  in	  Control	  and	  Bmal1lox/lox/Ren1dCre	  mice	  
	  	  
	   	   	  	   C	  	  	  	  	  	  	  	  	  Control	   Bmal1lox/lox/Ren1dCre	   p	  Body	  weight	  (g)	   26.7±3.4	  (33)	   26.5±2.4	  (33)	   NS	  	   	   	   	  
Urine	   	   	   	  Volume/g	  body	  weight	  (ml/g)	   0.068±0.028	  (33)	   0.084±0.029	  (33)	   0.029	  Osmolality	  (mosm/kg	  H2O)	   2937±605	  (12)	   2329±341	  (12)	   0.006	  pH	   6.29±0.17	  (12)	   6.11±0.23	  (12)	   0.050	  
	   	   	   	  UV*Na+/g	  body	  weight	  (µmol/g)	   11.8±3.2	  (12)	   10.0±1.3	  (12)	   NS	  UV*K+/g	  body	  weight	  (µmol/g)	   32.8±7.3	  (12)	   29.6±3.2	  (12)	   NS	  UV*Cl-­‐/g	  body	  weight	  (µmol/g)	   20.5±3.9	  (12)	   19.6±2.3	  (12)	   NS	  UV*Ca2+/g	  body	  weight	  (µmol/g)	   0.13±0.03	  (12)	   0.22±0.16	  (12)	   0.061	  UV*Mg2+/g	  body	  weight	  (µmol/g)	   2.17±0.50	  (12)	   2.67±0.70	  (12)	   0.059	  UV*PO43-­‐/g	  body	  weight	  (µmol/g)	   5.08±1.68	  (12)	   5.80±1.96	  (12)	   NS	  UV*Creatinine/g	  body	  wieght	  (µmol/g)	   0.52±0.09	  (12)	   0.57±0.14	  (12)	   NS	  UV*Urea/g	  body	  weight	  (µmol/g)	   146.8±27.4	  (12)	   146.9±19.6	  (12)	   NS	  UV*Urate/g	  body	  weight	  (µmol/g)	   78.3±14.2	  (12)	   73.4±16.6	  (12)	   NS	  UV*Glucose/g	  body	  weight	  (µmol/g)	   0.21±0.03	  (12)	   0.29±0.18	  (12)	   NS	  UV*Total	  protein/g	  body	  weight	  (mg/g)	   0.65±0.09	  (12)	   0.48±0.20	  (12)	   0.011	  
	   	   	   	  
Plasma	   	   	   	  Osmolality	  (mosm/kg	  H2O)	   311.1±6.0	  (9)	   305.1±3.6	  (8)	   0.026	  Na+	  (mM)	   158.2±0.7	  (9)	   157.2±0.9	  (9)	   NS	  K+	  (mM)	   4.68±0.10	  (9)	   4.74±0.16	  (9)	   NS	  Cl-­‐	  (mM)	   122.4±3.0	  (9)	   110.0±2.1	  (9)	   0.071	  Ca2+	  (mM)	   2.12±0.10	  (9)	   2.07±0.05	  (9)	   NS	  Mg2+	  (mM)	   1.28±0.09	  (9)	   1.27±0.04	  (9)	   NS	  Creatinine	  (µM)	   15.1±2.0	  (9)	   15.9±3.0	  (9)	   NS	  
	   	   	   	  
GFR	   	   	   	  GFR	  ZT6	  (µl/min)	   208.3±18.6	  (6)	   263.2±34.5	  (5)	   0.008	  GFR	  ZT18	  (µl/min)	   322.9±19.1	  (5)	   386.9±25.2	  (5)	   0.002	  	   	   	   	  Values	  are	  means	  ±	  SD.	  Student’s	  t-­‐test.	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